Goldman Sachs’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $35.1M | Buy |
|
|||||
|
2025
Q2 | $30.4M | Sell |
|
|||||
|
2025
Q1 | $43.3M | Sell |
|
|||||
|
2024
Q4 | $256M | Buy |
|
|||||
|
2024
Q3 | $108M | Buy |
|
|||||
|
2024
Q2 | $55.6M | Buy |
|
|||||
|
2024
Q1 | $47.7M | Buy |
|
|||||
|
2023
Q4 | $30.2M | Buy |
|
|||||
|
2023
Q3 | $21.9M | Sell |
|
|||||
|
2023
Q2 | $22.3M | Sell |
|
|||||
|
2023
Q1 | $18.7M | Buy |
|
|||||
|
2022
Q4 | $19.1M | Sell |
|
|||||
|
2022
Q3 | $11.7M | Buy |
|
|||||
|
2022
Q2 | $7.69M | Buy |
|
|||||
|
2022
Q1 | $8.27M | Buy |
|
|||||
|
2021
Q4 | $4.72M | Sell |
|
|||||
|
2021
Q3 | $6.25M | Buy |
|
|||||
|
2021
Q2 | $4.18M | Buy |
|
|||||
|
2021
Q1 | $3.58M | Sell |
|
|||||
|
2020
Q4 | $7.86M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $2.76M | Buy |
|